Introduction of the Rapid Deployment Aortic Valve System Use in Elderly Patients With Endocarditis

Frontiers in Cardiovascular Medicine

article

Alper Öner¹  Christoph Hemmer²  Anthony Alozie³  Benjamin Löser⁴  Pascal M. Dohmen³ 

[1] Department of Cardiology, Heart Center Rostock, University of Rostock;Department of Tropical Medicine and Infectious Diseases, University of Rostock;Department of Cardiac Surgery, Heart Center Rostock, University of Rostock;Department of Anesthesiology and Intensive Care Medicine, University of Rostock;Department of Cardiothoracic Surgery, Faculty of Health Science, University of the Free State

关键词: active infective endocarditis;    rapid-deployment valve system;    heart valve surgery;    aortic valve;    aortic valve endocarditis;   

DOI  :  10.3389/fcvm.2022.774189

学科分类：地球科学(综合)

来源: Frontiers

【 摘 要 】

Introduction: The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. Materials and Methods: Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. Results: Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). Conclusion: Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve.

【 授权许可】

CC BY